Study Evaluating IPI-504 in Patients With Gastrointestinal Stromal Tumors (GIST) Following Failure of at Least Imatinib and Sunitinib

This study has been terminated.

( Based on Independent Data Monitoring Committee (IDMC) recommendation. )

Study NCT00688766 Information provided by Infinity Pharmaceuticals

First Received: May 29, 2008 Last Updated: April 17, 2009 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been terminated.
Estimated Study Completion Date:	December 2011
Estimated Primary Completion Date:	August 2010 (Final data collection date for primary outcome measure)